Galapagos | GLPG - Trade Debtors



Galapagos reported EUR223.52M in Trade Debtors for its fiscal quarter ending in June of 2025.


Trade Debtors Change Date
argenx SE 1.2B 289.13M Jun/2025
AstraZeneca USD 16.24B 1.42B Jun/2025
Biogen USD 2.08B 87.5M Jun/2025
Genmab DKK 998M 199M Jun/2025
Gilead Sciences USD 4.78B 393M Jun/2025
GlaxoSmithKline GBP 7.7B 196M Jun/2025
GRIFOLS EUR 1.25B 213.13M Jun/2025
Hikma Pharmaceutical USD 973M 8M Dec/2024
Incyte USD 842.89M 19.76M Jun/2025
Merck EUR 4.92B 62M Jun/2025
Neurocrine Biosciences USD 595.7M 79.7M Jun/2025
Novartis USD 9.18B 451M Jun/2025
Roche Holding CHF 13.46B 984M Dec/2024
Sanofi 8.21B 7.76B Jun/2025
UCB EUR 1.58B 157M Dec/2024
Vertex Pharmaceuticals USD 1.89B 88.4M Jun/2025